Erin Murphy, MD, discusses remaining questions with stereotactic body radiotherapy in pediatric sarcoma.
Erin Murphy, MD
Advertisement
Articles by Erin Murphy, MD
Erin Murphy, MD, discusses the clinical implications of pazopanib plus stereotactic body radiotherapy in pediatric sarcoma.
Erin Murphy, MD, discusses the utility of pazopanib plus stereotactic body radiation therapy in pediatric sarcoma.
Erin Murphy, MD, associate staff, Department of Radiation Oncology, Cleveland Clinic, discusses a study examining prognostic factors of patients with glioma.
Advertisement
Latest Updated Articles
Dr. Murphy on Remaining Questions With SBRT in Pediatric SarcomaPublished: April 8th 2021 | Updated:
Dr. Murphy on Glioma Prognostic Factors in Younger PatientsPublished: January 6th 2016 | Updated:
- Dr. Murphy on the Clinical Implications of Pazopanib Plus SBRT in Pediatric Sarcoma
Published: April 7th 2021 | Updated:
Dr. Murphy on the Utility of Pazopanib Plus SBRT in Pediatric SarcomaPublished: January 29th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5